Stifel Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $18

Stifel analyst James Condulis has initiated coverage on Achieve Life Sciences (NASDAQ: ACHV) with a Buy rating. The firm has set a price target of $18 for the company's stock.